OS Therapies CEO on clinical advancements in immunotherapy for osteosarcoma
CEO & Founder Conversations
•
4m 43s
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
Up Next in CEO & Founder Conversations
-
OS Therapies CEO on its latest clinic...
Paul Romness, CEO of OS Therapies, tells us about the company’s progress since its August 2024 IPO and its latest clinical advancements in immunotherapy for osteosarcoma and other solid tumors on #NYSEFloorTalk with Judy Shaw.
-
Public Co-CEO + Co-Founder on how AI ...
Leif Abraham, Co-CEO & Co-Founder of Public, joined Judy Shaw on #NYSEFloorTalk to discuss how AI is shaping investor access to research, trends driving market interest, and how Public.com is navigating opportunities in stocks, bonds, and crypto. 📈🚀
-
Grove Collaborative CEO on its missio...
Jeff Yurcisin, CEO of Grove Collaborative, joined #NYSEFloorTalk to discuss the company’s mission to eliminate single-use plastics, its shift back to DTC, and what’s next for sustainable consumer products in 2025. #ICRConference2025
